Antimicrobial use in long-term-care facilities. 1996

L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
Long-Term-Care Committee, Society for Healthcare Epidemiology of America, Woodbury, NJ 08096-3172, USA.

There is intense antimicrobial use in long-term-care facilities (LTCF), and studies repeatedly document that much of this use is inappropriate. The current crisis in antimicrobial resistance, which encompasses the LTCF, heightens concerns of antimicrobial use. Attempts to improve antimicrobial use in the LTCF are complicated by characteristics of the patient population, limited availability of diagnostic tests, and virtual absence of relevant clinical trials. This article recommends approaches to management of common LTCF infections and proposes minimal standards for an antimicrobial review program. In developing these recommendations, the article acknowledges the unique aspects of provision of care in the LTCF.

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D009735 Nursing Homes Facilities which provide nursing supervision and limited medical care to persons who do not require hospitalization. Homes, Nursing,Nursing Home
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice
D017723 Drug Utilization Review Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993. Utilization Review, Drug,Drug Utilization Evaluation,Drug-Use Review,Evaluation, Drug Utilization,Review, Drug Utilization,Review, Drug-Use,Drug Use Review,Drug Utilization Evaluations,Drug Utilization Reviews,Drug-Use Reviews,Evaluations, Drug Utilization,Review, Drug Use,Reviews, Drug Utilization,Reviews, Drug-Use,Utilization Evaluation, Drug,Utilization Evaluations, Drug,Utilization Reviews, Drug

Related Publications

L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
May 2017, The Journal of antimicrobial chemotherapy,
L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
June 2018, Rhode Island medical journal (2013),
L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
February 1996, Infection control and hospital epidemiology,
L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
February 2012, Future microbiology,
L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
June 2014, Infectious disease clinics of North America,
L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
January 2014, Archives of gerontology and geriatrics,
L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
February 2016, Infection control and hospital epidemiology,
L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
December 2011, The Journal of antimicrobial chemotherapy,
L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
February 1999, American journal of infection control,
L E Nicolle, and D Bentley, and R Garibaldi, and E Neuhaus, and P Smith
July 2019, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!